Table 1.
Baseline clinical characteristics of patients.
| No. | Sex | Age | Pathology type | Stage | Pre/post-operative treatment |
Pre-operative edema | Underlying disease |
|---|---|---|---|---|---|---|---|
| 1 | F | 59 | IDC | IIIA | S+CTx/T | Yes | Hypertension |
| 2 | F | 65 | Sarcoma | IIIC | S+CTx/CTx | N | N |
| 3 | F | 63 | IDC | IIIC | S+RT/CTx | N | N |
| 4 | F | 83 | IDC | IV | None | N | Diabetes |
| 5 | F | 84 | IDC | IV | H | N | N |
| 6 | F | 52 | IDC | IIA | S+CTx/CTx | N | N |
| 7 | F | 89 | IDC | IIIB | None | Yes | Coronary heart disease |
| 8 | F | 89 | IDC | IV | None | N | Hypertension |
| 9 | F | 53 | IDC | IIB | CTx/H | N | Hypertension |
| 10 | F | 61 | IDC | IIIC | S+CTx/CTx | Yes | Diabetes |
| 11 | M | 68 | IDC | IIB | S+CTx/CTx | N | N |
| 12 | F | 78 | IDC | IIB | S+CTx/CTx | N | N |
| 13 | F | 86 | IDC | IV | S+CTx/T | N | Local ulcer |
| 14 | F | 58 | IDC | IV | S/RT+CTx | N | N |
| 15 | F | 63 | IDC | IV | RT+CTx/none | N | N |
IDC, invasive ductal cancer; S, surgery; RT, radiotherapy; CTx, chemotherapy; H, endocrine therapy; T, targeted therapy; N, none.